What does Tris do?
TRIS is a company that specializes in providing innovative technology solutions tailored to enhance operational efficiency. They focus on developing software and tools that streamline processes across various industries. With a commitment to quality and customer satisfaction, TRIS aims to empower businesses to achieve their goals through advanced technological support.
- Activities
-
No results found
- Signals
-
Juridical warningJuridical warning
The legal status points to elevated risk (e.g. dissolution or bankruptcy).
ProfitableProfitable € 4KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 40.02MStrong equity provides a buffer against setbacks.
Low riskLow risk 100.0%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 34,805.41A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 7.17MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 4KPositive EBITDA: operating activities are profitable.
Financial ratios
|
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
|
€
12K
|
€
-7K
|
|
|
|
|
€
4K
|
€
-55K
|
€
-9K
|
€
-22K
|
|
|
€
7.17M
|
€
3.31M
|
€
2.11M
|
€
2.19M
|
|
|
€
40.02M
|
€
32.85M
|
€
29.54M
|
€
27.44M
|
|
|
100%
|
93.89%
|
90.2%
|
77.69%
|
|
|
€
947
|
€
2.14M
|
€
3.21M
|
€
7.88M
|
|
|
€
32.11M
|
€
359K
|
€
46K
|
€
132K
|
Publications 55
All publications- Ontslagen - Benoemingen 28/07/2023
- Rubriek Einde (Stopzetting, Intrekking Stopzetting, Nietigheid, Ger. Ak., Gerechtelijke Reorganisatie, Enz... - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 24/07/2023
- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 26/05/2023
- Ontslagen - Benoemingen 11/08/2022
- Ontslagen - Benoemingen 20/08/2021
News
Show all- O In An Aqueous Solution: Suppressing Electrochemical Formation Of Coo ACS Publications 1 year ago
- Tris Pharma To Present New Data At Aapm Painconnect Annual Meeting And Showcase Potential Of Cebranopadol, A First-In-Class Investigational Dual-Nmr Agonist For The Treatment Of Pain BioSpace 1 year ago
- Flame-Retardant Tris(2-Chloroethyl) Phosphate: Assessing The Effects On Microalgae, Mussel Hemocytes And Human Peripheral Blood Cells ScienceDirect.com 1 year ago
- Tris Speaker | Hall Of Fame, Boston Red Sox, Outfielder Britannica 1 year ago
- View Tris Kington's Obituary And Express Your Condolences Legacy.com 1 year ago
Frequently asked questions
Answers to the most common questions about Tris, based on official government data and the filed annual accounts.
What is the VAT number of Tris?
The VAT number of Tris is BE0453.984.447.
When was Tris established?
Tris was founded in 15-12-1994.
What is the official address of Tris?
The official address of Tris is Onafhankelijkheidslaan 17-18 Gent 9000.
What is the legal form of Tris?
The juridical form of Tris is Public limited company (NV/SA).
What is the annual revenue of Tris?
The 2022 accounts of Tris do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Tris do?
TRIS is a company that specializes in providing innovative technology solutions tailored to enhance operational efficiency. They focus on developing software and tools that streamline processes across various industries. With a commitment to quality and customer satisfaction, TRIS aims to empower businesses to achieve their goals through advanced technological support.
Is Tris a reliable company?
Tris is a registered Rechtspersoon with company number 0453.984.447 and can be verified through the official CBE database.
What is the credit limit of Tris?
The estimated credit limit of Tris is €2,135,730.
Is Tris still active?
Tris currently has the status "Fusie door overneming" and is not active.